ARCH Venture Partners XII, LLC is 10% Owner at Neumora Therapeutics, Inc. (NMRA). They have made 2 open-market trades across 2 companies since 2023, most recently 2026-05-04.
CIK 0001979548
2 open-market purchases totalling $20.6M since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SPTX | 6,294,951 | $112.1M |
| PRME | 3,200,000 | $11.1M |
| NMRA | 6,046,907 | $2.9M |
| Total | $126.1M |
Shares reported on the most recent Form 4, priced at the 2026-05-04 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.